Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -336 | -9,280 | -80,954 | -55,512 | -22,397 |
| Depreciation Amortization | 31,785 | 31,774 | 64 | 30 | 122 |
| Accounts receivable | -24,493 | -1,107 | -2,303 | -2,886 | N/A |
| Accounts payable and accrued liabilities | -249 | 807 | -1,875 | -1,098 | 1,200 |
| Other Working Capital | -48,630 | -29,918 | -24,703 | -12,111 | 861 |
| Other Operating Activity | -26,955 | -48,554 | 68,155 | 53,102 | -10,623 |
| Operating Cash Flow | $-68,878 | $-56,278 | $-41,616 | $-18,475 | $-30,837 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -49 | N/A | -8 |
| Investing Cash Flow | $-4 | $-4 | $-49 | $N/A | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 176,130 | 176,129 | 137,312 | 73,051 | 38,113 |
| Other Financing Activity | -1 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $176,129 | $176,129 | $137,312 | $73,051 | $38,113 |
| Beginning Cash Position | 55,409 | 55,409 | 55,409 | 55,409 | 48,141 |
| End Cash Position | 162,656 | 175,256 | 151,056 | 109,985 | 55,409 |
| Net Cash Flow | $107,247 | $119,847 | $95,647 | $54,576 | $7,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,878 | -56,278 | -41,616 | -18,475 | -30,837 |
| Capital Expenditure | -4 | -4 | -49 | N/A | -8 |
| Free Cash Flow | -68,882 | -56,282 | -41,665 | -18,475 | -30,845 |